PharmiWeb.com - Global Pharma News & Resources
22-Jul-2019

Eckert & Ziegler Increases Profit Forecast to 4 Euro per Share.

Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Change in Forecast/Preliminary Results
Eckert & Ziegler Increases Profit Forecast to 4 Euro per Share.

22-Jul-2019 / 19:19 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Insider information pursuant to Article 17 MAR

Eckert & Ziegler Increases Profit Forecast to 4 Euro per Share

Berlin, 22 July 2019. According to initial analyses, revenues and earnings of the Berlin based isotope specialists Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700) as of June 30 were significantly higher than expected. While sales of EUR 81.0 million were generated in 2018 with continuing operations, this value is expected to have increased by 10% to EUR 89.0 million as of the half-year reporting date in 2019. In the same period, the earnings from continuing operations increased by 56% from EUR 1.65 to EUR 2.59 per share according to preliminary figures.

Since the 2019 half-year result contains only a few extraordinary items and most main product groups continue to be in good demand, the Executive Board expects that the consolidated result from continuing operations for fiscal year 2019 to exceed the forecast published at the beginning of the year. The previous target of EUR 3.50 is therefore increased to EUR 4.00 per share.

The complete figures for the first half year 2019 will be published on 13 August 2019.

Your contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin
Tel.: +49 (0) 30 / 94 10 84-138, karolin.riehle@ezag.de, www.ezag.de


22-Jul-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Eckert & Ziegler Strahlen- und Medizintechnik AG
Robert-Rössle-Str.10
13125 Berlin
Germany
Phone: +49 30 941084-138
Fax: +49 30 941084-112
E-mail: karolin.riehle@ezag.de
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 844899

 
End of Announcement DGAP News Service

Editor Details

Last Updated: 22-Jul-2019